News
Languages: English The United States Food and Drug Administration (FDA) has approved another vaccine maker to create a shot to help prevent COVID-19, with caveats. Newsweek has reached out to ...
Coronavirus vaccines are still recommended for healthy children if their doctors approve, according to updated immunization schedules published late Thursday by the Centers for Disease Control and ...
Unlike traditional vaccines that intensify a particular part of the immune system, these new treatments are known as “inverse vaccines,” as they suppress specific parts of the immune system.
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...
Editor's note: This story was updated on May 22, 2025, to include new information about FDA plans to change COVID-19 vaccine recommendations. May 22, 2025 – COVID-19 vaccines are making ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to ...
But the FDA framework, published Tuesday in the New England Journal of Medicine, urges companies to conduct large, lengthy studies before tweaked vaccines can be approved for healthier people.
The Food and Drug Administration has approved the Novavax COVID-19 vaccine—with strict conditions. Coming after four years of clinical trials, the vaccine will only be available for older adults ...
But the FDA framework, published Tuesday in the New England Journal of Medicine, urges companies to conduct large, lengthy studies before tweaked vaccines can be approved for healthier people.
Older adults are being warned against receiving the chikungunya vaccine before traveling. The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results